Reuters -- An analysis by U.S. regulators found Bristol-Myers Squibb and Elan Corp's antibiotic Maxipime was not associated with a higher rate of death compared with similar drugs, the Food and Drug Administration said on Wednesday.
Reuters -- An analysis by U.S. regulators found Bristol-Myers Squibb and Elan Corp's antibiotic Maxipime was not associated with a higher rate of death compared with similar drugs, the Food and Drug Administration said on Wednesday.
